Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Transdermal Drug Delivery Market is Growing at a CAGR of 9.8% during the Study Period from 2021 to 2026, Asserts DelveInsight

This image opens in the lightbox

News provided by

DelveInsight Business Research, LLP

14 Dec, 2021, 16:30 GMT

Share this article

Share toX

Share this article

Share toX

The transdermal Drug Delivery market is increasing owing to the rising prevalence of patients afflicted with chronic disorders and the rising adoption of third-generation transdermal drug delivery systems

LAS VEGAS, Dec. 14, 2021 /PRNewswire/ -- DelveInsight published a new report on "Transdermal Drug Delivery Market & Competitive Landscape," providing an in-depth market understanding for transdermal drug delivery which will further benefit the competitors or stakeholder operating in the transdermal drug delivery arena.

Recent Developmental Activities In Transdermal Drug Delivery Devices Market:

  • On December 07, 2020, Hisamitsu Pharmaceutical Co., Inc. had announced that the transdermal, pain treatment NSAID patch had achieved the primary endpoint of the LP03 study, Phase III clinical study for "low back pain" and the LP04 study, Phase III clinical study for "humeroscapular periarthritis, cervico-omo-brachial syndrome and tenosynovitis" in Japan.
  • On July 21, 2020, Hisamitsu Pharmaceutical Co., Inc. announced that it has obtained approval of manufacturing and marketing for OABLOK® PATCH in Thailand.
  • On October 15, 2019, Noven Pharmaceutical's Secuado (asenapine) transdermal system had received Food and Drug Administration's approval to treat schizophrenia patients.

Interested in knowing how the Transdermal Drug Delivery Market will be growing by 2026? Click to get a snapshot of Transdermal Drug Delivery Market Analysis

Transdermal Drug Delivery Devices Overview 

Transdermal Drug Delivery devices are devices that are used for delivering biologically active agents through the skin, majorly by diffusion, for locally internal or systemic effects. These are preferred alternatives that work effectively in place of oral drug delivery and hypodermic injections. 

The transdermal drug delivery devices consist of relatively high amounts of Active Pharmaceutical Ingredients (APIs) mainly incorporated into a polymeric matrix. Polymer used in this transdermal drug delivery system allows the drug to diffuse properly and get released through it. 

To get a deeper understanding of the driving factors related to the transdermal drug delivery market, get a snapshot of the Transdermal Drug Delivery Market Dynamics

Geography-Wise Transdermal Drug Delivery Market Analysis

Geographically, the global transdermal drug delivery market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. North America tends to dominate the global transdermal drug delivery market in the present scenario in terms of market share. It is anticipated to continue to dominate during the forecast period. However, the domination shown by North America will be prominently challenged by the European market. This supremacy witnessed in North America is attributed to the rising prevalence of cardiovascular disorder, growing central nervous system disorders, and the preferred choice of non-invasive drug delivery methods by patients, and already established key manufacturers in the North American region. 

However, there are great opportunities for market penetration for European regions as the major companies already have a grip in developed regions.  Further, due to the growing chronic disorders, the adoption of third-generation transdermal drug delivery devices by patients, and key players in European regions. There is an increasing demand observed for transdermal drug delivery in these regions, thereby positively influencing the overall transdermal drug delivery market. 

To gain a better understanding of the European Transdermal Drug Delivery Market, click to get a snapshot of Transdermal Drug Delivery Market Analysis

Covid-19 Impact on Transdermal Drug Delivery Devices Market 

The market for Transdermal Drug Delivery had observed a period of reduced growth owing to the outbreak of COVID-19. Various elective procedures were temporarily stopped in contrast to the COVID-19 affected patients that were given utmost priority because of the COVID-19 pandemic. Apart from this, several other factors, including the lockdown-related restrictions, patient reluctance to visit the hospitals and clinics, logistical issues, and the temporary closing of manufacturing companies, had further affected the healthcare system. 

However, post-COVID-19, the healthcare system is trying to get normalcy due to the resumed patent visits, the opening of manufacturing facilities, and leverage given in terms of lockdown restrictions. Apart from all these factors, an increase in the recent approvals of the transdermal drug delivery, the rise in research and development of technologically advanced transdermal drug delivery in COVID-19 patients, and the increase in mergers and acquisitions between the key players active in this arena have increased the demand for transdermal drug delivery. 

Transdermal Drug Delivery Devices Market Segmentation

  • By Type of Devices
    • Drug-in-adhesive Patches
    • Matrix Patches
    • Reservoir Membrane Patches
    • Microneedle Patches
  • By Application
    • Pain Management
    • Central Nervous System Disorders
    • Hormonal Applications
    • Cardiovascular Diseases
    • Others
  • By End-User
    • Hospitals
    • Ambulatory Surgical Centers 
    • Others 
  • By Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of World

The global transdermal drug delivery market by device type is categorized into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and microneedle patches.

Various benefits offered by the transdermal drug delivery devices in contrast to the oral or systemic dosage systems, such as the controlled release of drugs via the skin of patients, tend to reduce the first-pass metabolism effects, reduction of systemic side effects, and improvement in the dosage of efficacy by allowing steadier blood drug profiles throughout treatment, thereby enhancing patient compliance. Also, the recent launches of transdermal patches will aid in bolstering the transdermal drug delivery devices market. 

Therefore, due to the approval and launch of such technologically advanced transdermal drug delivery in the market, there will be a growth observed in demand for transdermal drug delivery. 

Transdermal Drug Delivery Device Market Scope

  • Study Period: 2018-2026
  • Key Companies: Hisamitsu Pharmaceutical, Mylan, UCB SA, Novartis, GlaxoSmithKline, Boehringer Ingelheim, Johnson & Johnson, Endo International, Purdue Pharma, Bristol-Myers Squibb Company, Endo Pharmaceuticals Inc., Acrux Limited, Lavipharm, Lead Chemicals Co. Inc., Luye Pharma Group and others.
  • Market Segmentation: By Type, By Application, By End-User, and By Geography
  • Geography Covered: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)

Table of Contents

1

Transdermal Drug Delivery Devices Report Introduction

2

Transdermal Drug Delivery Devices Market Executive Summary

2.1 Scope of the Study

2.2 Market at Glance

2.3 Competitive Assessment

2.4 Financial Benchmarking

3

Regulatory and Patent Analysis

1.        The United States
2.        Europe
3.        Japan
4.        China

4

Transdermal Drug Delivery Devices Market Key Factors Analysis

1.      Transdermal Drug Delivery Devices Market Drivers
2.      Transdermal Drug Delivery Devices Market Restraints and Challenges
3.      Transdermal Drug Delivery Devices Market Opportunities 

5

Transdermal Drug Delivery Devices Porter's Five Forces Analysis

5.1 Bargaining Power of Suppliers

5.2 Bargaining Power of Consumers

5.3 Threat of New Entrants

5.4 Threat of Substitutes 

5.5 Competitive Rivalry

6

COVID-19 Impact Analysis on Transdermal Drug Delivery Devices Market

7

Transdermal Drug Delivery Devices Market layout

 7.1   By Type of Devices

 7.2   By Application

 7.3   By End-user

 7.4   By Geography

8

Transdermal Drug Delivery Devices Global Company Share Analysis – Key 3-5 Companies

9

Transdermal Drug Delivery Devices Company and Product Profiles

9.1 Hisamitsu Pharmaceutical

9.2 Mylan

9.3 UCB SA

9.4 Novartis

9.5 GlaxoSmithKline

9.6 Boehringer Ingelheim

9.7 Johnson & Johnson

9.8 Endo International

9.9 Purdue Pharma

9.10 Bristol-Myers Squibb Company

9.11 Endo Pharmaceuticals Inc.

9.12 Acrux Limited

9.13 Lavipharm

9.14 Lead Chemicals Co. Inc.

9.15 Luye Pharma Group

10

Project Approach

11

KOL Views

12

DelveInsight Capabilities

13

Disclaimer

14

About DelveInsight

Related Reports

  • Syringes Market Insight, Competitive Landscape & Forecast 

DelveInsight's Syringes Market Insights, Competitive Landscape, and Market Forecast-2026 report delivers an in-depth understanding of Syringes and Competitive Landscape analysis.  Key players involved in this market are Becton, Dickinson and Company, Terumo Corporation, Medtronic plc, Smiths Medical, B. Braun Medical Inc., NIPRO Corporation, Hindustan Syringes & Medical Devices Limited, Gerresheimer AG, SCHOTT AG, CODAN Medizinische Geräte GmbH & Co KG and others.

  • Diabetes Pen Market Insight, Competitive Landscape & Forecast 

DelveInsight's Diabetes Pen Market Insights, Competitive Landscape, and Market Forecast-2026 report delivers an in-depth understanding of Diabetes Pen and Competitive Landscape analysis.  Key players involved in this market are AstraZeneca plc, Becton, Dickinson, and Company, Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Jiangsu Delfu Co., Medtronic Plc, Novo Nordisk A/S, Owen Mumford Ltd, Sanofi S.A, and Ypsomed Holding AG., and others.

  • Needle-Free Injection Market Insight, Competitive Landscape & Forecast 

DelveInsight's Needle-Free Injection Market Insights, Competitive Landscape, and Market Forecast-2026 report delivers an in-depth understanding of Needle-Free Injection and Competitive Landscape analysis.  Key players involved in this market include Antares Pharma, Inc., Endo International plc, PharmaJet, Bioject Medical Technologies Inc., Medical International Technology, Inc., INJEX Pharma AG, National Medical Products Inc., Valeritas, Inc., European Pharma Group, PenJet Corporation, Crossject SA, and others.

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also provides Business Consulting Services with a credible market analysis that will help accelerate the business growth and overcome challenges with a practical approach. 

Contact Us:
Shruti Thakur 
info@delveinsight.com   
+1(919)321-6187 
www.delveinsight.com

Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg

Modal title

Also from this source

Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight

Comprehensive Lewy Body Dementia Market Analysis of Evolving Trends and Anticipated Growth Trajectory During the Forecast Period (2025-2034) | DelveInsight

Lewy body dementia (LBD) is a progressive neurological condition characterized by the accumulation of abnormal alpha-synuclein protein in the brain....

Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight

Anti-GPC3 Therapies Market Gains Traction with Key Players Advancing Pipeline for Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Gastric Cancer, and Others | DelveInsight

DelveInsight's Anti-GPC3 Targeted Therapies Market Size, Target Population, Competitive Landscape & Market Forecast report includes a comprehensive...

More Releases From This Source

Explore

Pharmaceuticals

Pharmaceuticals

Health Care & Hospitals

Health Care & Hospitals

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.